SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Cochran Scott D.

(Last) (First) (Middle)
C/O REINSURANCE GROUP OF AMERICA, INC.
1370 TIMBERLAKE MANOR PARKWAY

(Street)
CHESTERFIELD MO 63017

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/28/2012
3. Issuer Name and Ticker or Trading Symbol
REINSURANCE GROUP OF AMERICA INC [ RGA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 5,500 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to purchase) 2010 12/31/2011(2) 02/19/2020 Common Stock 7,174 $47.1 D
Stock Option (right to purchase) 2008 12/31/2009(2) 02/20/2018 Common Stock 3,941 $56.03 D
Stock Appreciation Right (right to purchase) 2012 (1) 02/28/2022 Common Stock 10,563 $56.65 D
Stock Option (right to purchase) 2009 12/31/2010(2) 02/18/2019 Common Stock 6,116 $32.2 D
Stock Appreciation Right (right to purchase) 2011 12/31/2011(1) 02/22/2021 Common Stock 8,326 $59.74 D
Stock Option (right to purchase) 2007 12/31/2008(2) 02/20/2017 Common Stock 2,981 $59.63 D
Stock Option (right to purchase) 2006 12/31/2007(2) 02/21/2016 Common Stock 1,864 $47.48 D
Stock Option (right to purchase) 2005 12/31/2006(2) 01/27/2015 Common Stock 1,886 $47.47 D
Explanation of Responses:
1. SARS grants vest in four equal annual installments of 25%, on December 31 of the first four years after grant date.
2. Options vest and become exercisable in four equal annual installments of 25%, on December 31 of the second, third, fourth and fifth years after grant date.
Remarks:
Attached Exhibit 24 - Power of Attorney for Scott D. Cochran
/s/ William L. Hutton, as Attorney-in-Fact for Scott D. Cochran 02/29/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.